AGIOS PHARMACEUTICALS

Lobbying for AGIOS PHARMACEUTICALS · Pharmacy, Medicare/Medicaid, Health Issues

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $20,000.00 expenses · posted Jan 20, 2026

Lobbying activity 3

Health Issues

Sickle Cell policy Biotech innovation

Medical/Disease Research/Clinical Labs

Biotech Innovation

Medicare/Medicaid

Medicaid Reform

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.